Atrys Health, S.A.
MSE:ATRY.MC
3.14 (EUR) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 201.569 | 186.994 | 121.014 | 31.396 | 14.837 | 7.294 | 6.035 | 4.561 | 2.866 | 1.09 | 1.019 | 1.079 |
| Cost of Revenue
| 170.027 | 32.481 | 20.121 | 7.146 | 2.639 | 0.422 | 0.141 | 0.117 | 0.759 | 1.002 | 1.946 | 2.005 |
| Gross Profit
| 31.542 | 154.513 | 100.893 | 24.251 | 12.198 | 6.872 | 5.894 | 4.444 | 2.106 | 0.087 | -0.927 | -0.926 |
| Gross Profit Ratio
| 0.156 | 0.826 | 0.834 | 0.772 | 0.822 | 0.942 | 0.977 | 0.974 | 0.735 | 0.08 | -0.91 | -0.858 |
| Reseach & Development Expenses
| 3.116 | 1.669 | 1.94 | 1.26 | 1.633 | 0.301 | 0.301 | 0.276 | 0.092 | 0.095 | 0.629 | 0.757 |
| General & Administrative Expenses
| 6.089 | 18.004 | 14.149 | 3.076 | 0 | 0 | 1.834 | 1.751 | 0.172 | 0.019 | 0.016 | 0.017 |
| Selling & Marketing Expenses
| 0.785 | 0.788 | 0.678 | 0.213 | 0 | 0 | 0 | 0 | 0.008 | 0.006 | 0.007 | 0.014 |
| SG&A
| 29.702 | 18.792 | 14.827 | 8.359 | 4.167 | 2.357 | 1.834 | 1.751 | 0.18 | 0.025 | 0.023 | 0.031 |
| Other Expenses
| 1.954 | 134.37 | 98.458 | 22.456 | 11.008 | 0.064 | -0.106 | -0 | -0.179 | 0 | 0 | 0 |
| Operating Expenses
| 27.748 | 154.831 | 113.285 | 22.456 | 11.008 | 6.166 | 5.367 | 4.541 | 0.536 | -0.535 | -1.651 | -1.776 |
| Operating Income
| 3.794 | 8.368 | -12.341 | 0.983 | 1.215 | 0.77 | 0.421 | 0.475 | 0.214 | 0.453 | -0.121 | 0.08 |
| Operating Income Ratio
| 0.019 | 0.045 | -0.102 | 0.031 | 0.082 | 0.106 | 0.07 | 0.104 | 0.075 | 0.416 | -0.119 | 0.074 |
| Total Other Income Expenses Net
| -34.6 | -33.061 | -12.541 | -2.292 | -1.008 | -0.771 | -0.887 | 0.351 | 0.862 | -0.353 | -0.354 | -0.304 |
| Income Before Tax
| -30.806 | -24.693 | -24.882 | -1.309 | 0.207 | 0.064 | -0.648 | -0.145 | 1.001 | 0.097 | -0.476 | -0.227 |
| Income Before Tax Ratio
| -0.153 | -0.132 | -0.206 | -0.042 | 0.014 | 0.009 | -0.107 | -0.032 | 0.349 | 0.089 | -0.468 | -0.21 |
| Income Tax Expense
| -0.051 | -1.225 | -1.685 | 0.707 | 0.311 | 0.052 | -0.746 | -0.208 | -0.294 | -0.223 | -0.813 | -0.908 |
| Net Income
| -45.59 | -23.468 | -23.197 | -2.015 | -0.105 | 0.012 | 0.097 | 0.063 | 1.295 | 0.32 | 0.337 | 0.682 |
| Net Income Ratio
| -0.226 | -0.126 | -0.192 | -0.064 | -0.007 | 0.002 | 0.016 | 0.014 | 0.452 | 0.294 | 0.33 | 0.632 |
| EPS
| -0.6 | -0.34 | -0.43 | -0.071 | -0.005 | 0.001 | 0.027 | 0.006 | 0.16 | 0.04 | 0.042 | 0.084 |
| EPS Diluted
| -0.6 | -0.34 | -0.43 | -0.071 | -0.005 | 0.001 | 0.027 | 0.006 | 0.16 | 0.04 | 0.042 | 0.084 |
| EBITDA
| 33.467 | 38.713 | 8.447 | 4.808 | 3.068 | 2.034 | 1.712 | 1.153 | 1.862 | 0.661 | 0.196 | 0.526 |
| EBITDA Ratio
| 0.166 | 0.207 | 0.07 | 0.153 | 0.207 | 0.279 | 0.284 | 0.253 | 0.65 | 0.607 | 0.192 | 0.488 |